Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma-Reference-Cited by-同舟云学术

Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma

Published:2017-03-16 Issue:4 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chauhan Bhupendrasinh F¹²³⁴,Jeyaraman Maya M³,Singh Mann Amrinder³,Lys Justin³,Abou-Setta Ahmed M³,Zarychanski Ryan³⁵⁶⁷,Ducharme Francine M⁴⁸⁹

Affiliation:

1. Children’s Hospital Research Institute of Manitoba; Biology of Breathing Group; Winnipeg Canada

2. University of Manitoba; College of Pharmacy; Winnipeg MB Canada

3. University of Manitoba; Knowledge Synthesis Platform, George and Fay Yee Centre for Healthcare Innovation; Winnipeg Canada

4. University of Montreal; Department of Paediatrics; Montreal Canada

5. University of Manitoba; Community Health Sciences; Winnipeg MB Canada R3A 1R9

6. CancerCare Manitoba; Department of Haematology and Medical Oncology; Winnipeg Canada R3E 0V9

7. University of Manitoba; Department of Internal Medicine; Winnipeg Canada

8. CHU Sainte-Justine; Research Centre; Montreal Canada

9. University of Montreal; Department of Social and Preventive Medicine; Montreal Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference130 articles.

1. Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control;Barnes;Respiratory Medicine,2007

2. Bateman ED Holgate ST Binks SM Tarna IP A multicentre study to assess the steroid-sparing potential of Accolate (zafirlukast; 20 mg bd) Allergy P 0709

3. Comparative evaluation of moderate dose inhalational corticosteroid (ICS) fluticasone with the combination of low dose fluticasone and montelukast in moderate persistent bronchial asthma;Beg;International Journal of Medical Science and Public Health,2014

4. Low doses of budesonide (B) plus montelukast (M) versus high doses of budesonide in asthmatic patients [abstract];Bilancia;American Journal of Respiratory and Critical Care Medicine,2000

5. The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients;Cakmak;Tohoku Journal of Experimental Medicine,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacological management of asthma in adults: 2023 update;Expert Opinion on Pharmacotherapy;2024-03-03

2. Medication utilization for patients with chronic rhinosinusitis with nasal polyposis and asthma in 12 months pre‐ and post‐dupilumab initiation;International Forum of Allergy & Rhinology;2024-02-26

3. Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years;Monaldi Archives for Chest Disease;2023-09-07

4. Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?;European Respiratory Journal;2023-07-20

5. Effect of High-Intensity Interval Training on Inhaled Corticosteroid Dose in Asthma Patients: A Randomized Controlled Trial;The Journal of Allergy and Clinical Immunology: In Practice;2023-07